Dynavax Technologies Corp (NASDAQ:DVAX)

11.18
Delayed Data
As of May 19
 +1.56 / +16.22%
Today’s Change
7.26
Today|||52-Week Range
21.39
-20.54%
Year-to-Date
Why Dynavax Stock Blasted 16% Higher Today
May 19 / MotleyFool.com - Paid Partner Content
Why Dynavax Stock Won on a Losing Monday for the Market
May 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close9.62
Today’s open9.62
Day’s range9.62 - 11.26
Volume267,040
Average volume (3 months)2,317,132
Market cap$1.2B
Data as of 4:03pm ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+124.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+838.85%
P/E ratio14.3
Price/Sales4.28
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
AXSMAxsome Therapeutics ...+0.40+1.28%
PRTAProthena Corporation...+0.68+2.66%
SRRASierra Oncology Inc+0.06+0.11%
XNCRXencor Inc+0.45+2.00%
Data as of 4:03pm ET, 05/19/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)$0.29
Annual revenue (last year)$437.0M
Annual profit (last year)$72.1M
Net profit margin16.51%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Emeryville, California

Forecasts